KH

Krishnappa Hemalatha

Active Director Director DIN 11113971
DIN 11113971 First appointment May 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Krishnappa Hemalatha

Data last updated:

Krishnappa Hemalatha is a Director at Cutifix Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11113971
Primary Designation Director
Industry Pharma
First Appointment 19 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 May 20252025Active

Board colleagues of Krishnappa Hemalatha

Directorship timeline

Open interactive timeline →
Cutifix Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Krishnappa Hemalatha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishnappa Hemalatha

Krishnappa Hemalatha currently holds 1 directorship: Cutifix Pharmaceuticals Private Limited (Director, since 19 May 2025).

Krishnappa Hemalatha was first appointed on 19 May 2025 as Director at Cutifix Pharmaceuticals Private Limited.

The current boards of Krishnappa Hemalatha's companies include Bangalore Krishna Rakshitha (Cutifix Pharmaceuticals Private Limited), Thimmaraj Naveen (Cutifix Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available